| Financial Year |
March 31 2023 |
| Monetary Funds |
569,510,625.05 |
| Held-for-trading Financial Assets |
664,164,464.82 |
| Notes Receivable |
8,953,968.89 |
| Accounts Receivable |
28,292,177.69 |
| Advances to Suppliers |
4,401,639.36 |
| Other Receivables |
1,028,805,573.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
92,742,226.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
52,016,214.89 |
| Other Current Assets |
49,289,043.92 |
| Total Current Assets |
2,506,442,078.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
145,063,001.50 |
| Long-term Equity Investment |
291,715,143.30 |
| Investment Properties |
61,628,261.92 |
| Fixed Assetes |
794,078,799.83 |
| Under-construction Projects |
2,842,117.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
187,957,171.31 |
| R&D expenses |
-- |
| Goodwill |
14,940,740.40 |
| Long-Term Deferred and Prepaid Expenses |
6,383,264.93 |
| Deferred Income Tax Assets |
24,847,254.96 |
| Other Non-Current Assets |
4,395,122.63 |
| Sub-Total of Non-Current Assets |
1,648,801,045.67 |
| Total Assets |
4,155,243,124.65 |
| Short-Term Loans |
367,889,278.31 |
| Trading Financial liabilities |
-- |
| Notes Payable |
59,434,246.62 |
| Accounts Payable |
70,312,678.11 |
| Accounts Received In Advance |
4,354,451.11 |
| Employee Compensation Payable |
57,305,433.18 |
| Taxes Payable |
23,850,648.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
378,558,281.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
412,539,123.86 |
| Other Current Liabilities |
23,908,007.82 |
| Sub-Total of Current Liabilities |
1,428,853,349.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,201,893.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,839,344.54 |
| Total Liabilities |
1,507,692,694.32 |
| Paid-In Capital(Or Share Stock) |
1,212,152,157.00 |
| Capital Surplus |
264,690,035.49 |
| Surplus Reserve |
110,241,747.06 |
| LESS:Treasury Stock |
39,686,247.19 |
| Undistributed Profits |
848,428,324.01 |
| Minority Stockholder's Interest |
248,700,089.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,398,850,340.80 |
| Owner's Equity（Stockholder's Equity） |
2,647,550,430.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,155,243,124.65 |
